ARTICLE, Development/Plasticity/Repair

Developmental Regulation of a Local Positive Autocontrol of Supraoptic Neurons

Vivien Chevaleyre, Govindan Dayanithi, Françoise C. Moos and Michel G. Desarménien
Journal of Neuroscience 1 August 2000, 20 (15) 5813-5819; DOI: https://doi.org/10.1523/JNEUROSCI.20-15-05813.2000

Abstract

Mature oxytocin (OT) and vasopressin (AVP) magnocellular neurons of the hypothalamic supraoptic nuclei (SON) autocontrol their electrical activity via somatodendritic release of their respective peptides. Because OT and AVP are synthesized early in development and could play an important role in the maturation of these neurons, we checked whether the peptides are released within the SON and act on their secreting neurons during 3 weeks of postnatal development. We used patch-clamp recordings from SON neurons in rat hypothalamic horizontal slices to show that the spontaneous electrical activity of immature SON neurons is blocked by OT or AVP receptor antagonists, demonstrating a basal somatodendritic release of the peptides. Application of OT or AVP depolarizes SON neurons and stimulates activity typical of the corresponding mature neurons. This effect is directly on SON neurons because it is recorded in dissociated neurons. Radioimmunoassays from isolated SON were used to show that each peptide facilitates its own release at a somatodendritic level, exhibiting a self-sustaining positive feedback loop. This autocontrol is not uniform during development because the proportion of neurons depolarized by the peptides, the amplitude of the depolarization, and the propensity of the peptides to facilitate their own release are maximal during the second postnatal week and decrease thereafter. These data are consistent with a role of autocontrol in the maturation of SON neurons because it is maximal during the delimited period of postnatal development that corresponds to the period of major synapse formation.

Hypothalamic supraoptic nuclei (SON) contain two populations of magnocellular neurons that project to the neurohypophysis and secrete either oxytocin (OT) or vasopressin (AVP) into the blood circulation. The peptides are very similar, and the neurons are morphologically indistinguishable. However, the two types of neurons belong to specific networks, respond to distinct physiological stimuli (Leng et al., 1999) and display highly characteristic electrical activities (Poulain and Wakerley, 1982). In addition to being secreted as hormones by axon terminals in the neurohypophysis, OT and AVP are released at the somatodendritic level (Di Scala-Guenot et al., 1987; Pow and Morris, 1989) and optimize the electrical activity of their secreting neurons (Freund-Mercier and Richard, 1984; Gouzenes et al., 1998) via an autocrine–paracrine mechanism. AVP acts by favoring a phasic activity in AVP-secreting neurons (Gouzenes et al., 1998), i.e., a succession of active and silent periods being best suited for maximal AVP secretion (Cazalis et al., 1985). OT is known to enhance the amplitude and frequency of the high-frequency bursts of action potentials that occur simultaneously on all OT neurons during parturition and lactation and induce the pulsatile release necessary for delivery of the fetus and milk ejection (Moos et al., 1998). Both effects are complex and cannot be described as simple excitation or inhibition. The membrane mechanisms supporting OT and AVP actions on electrical activity of SON neurons are not elucidated, although it is known that they involve specific receptors and that both peptides act specifically on their secreting neurons to increase intracellular calcium (Dayanithi et al., 1996).

Both peptides are synthesized at birth (Lazcano et al., 1990), but neither OT nor AVP exerts its main adult physiological role yet (reproduction and regulation of water balance) (Rajerison et al., 1976). In view of their early expression and putative role as developmental factors on both central and peripheral structures (Carter et al., 1993), OT and AVP released locally and acting specifically on their secreting neurons could thus contribute to the maturation of SON neurons. This study was designed to test whether postnatal SON neurons are autocontrolled by somatodendritic release of their peptide. Our results show that OT and AVP depolarize immature SON neurons and that endogenous peptide release is involved in the spontaneous activity of these neurons. Moreover, each peptide has a facilitatory effect on its own somatodendritic release, and all of these effects are maximal during the second postnatal week, suggesting important roles of this autocontrol in the maturation of SON neurons.

MATERIALS AND METHODS

Slice preparation. Male Wistar rats aged from postnatal day 0 to 20 (P0–P20) were killed by decapitation, and the brain was rapidly removed and bathed in cold (4°C) and oxygenated (95% O2 + 5% CO2) sucrose solution containing (in mm): sucrose 220, KCl 2.3, NaHCO3 26, CaCl2 2.5, glucose 10, KH2PO4 1.2, MgSO4 1.2, pH 7.4; 300 mOsm/l. A block of hypothalamus containing both SON was dissected, and horizontal slices (250–300 μm thick) were obtained using a Campden InstrumentsVibratome. Before recordings, slices were allowed to recover for 1–2 hr at room temperature in oxygenated (95% O2 + 5% CO2) artificial CSF (ACSF) containing (in mm): NaCl 110, KCl 1.2, NaHCO326, CaCl2 2, glucose 10, KH2PO4 1.2, MgCl2 2, pH 7.4; 300 mOsm/l.

Preparation of dissociated neurons. Male Wistar rats (P8) were killed by decapitation, the brain was rapidly removed, and two narrow tissue pieces lateral to the optic chiasma were dissected. The tissue pieces were incubated for 25 min in oxygenated ACSF (95% O2 + 5% CO2) supplemented with protease X (1 mg/ml) at room temperature, rinsed, and incubated for 25 min in oxygenated ACSF supplemented with protease XIV (1 mg/ml) and deoxyribonuclease I (650 U/ml). The tissue pieces were then rinsed and mechanically dissociated by trituration, and the cell suspension was plated in 35 mm culture dishes. The recordings began as soon as the cells were attached to the bottom of the dish (15–20 min).

Electrophysiological recordings. Slices or dissociated neurons were placed in a recording chamber under a Leica microscope (40×) and perfused with ACSF (34°C) at a rate of 2 ml/min. Current-clamp recordings were obtained with an Axoclamp 2A amplifier, filtered at 6 kHz, and digitized at 2 kHz. Data were stored and analyzed using the P-Clamp software (Axon Instruments). Pipettes (4–6 MΩ) were pulled with a horizontal puller (Flaming/Brown, Sutter Instruments) and filled with solution containing (in mm): KMeSO3 135, KCl 5, CaCl2 1, EGTA-Na 5, ATP-Mg 4, HEPES-Na 10, pH 7.2; 290 mOsm/l for whole-cell recordings and with solution containing (in mm): KCl 132.5, HEPES-Na 10, CaCl2 5, gramicidin 80 μg/ml for perforated-patch recordings (to preserve the Cl− equilibrium, which is known to change during development). Series resistance and cell capacitance and resistance were measured using a 10 mV hyperpolarizing square pulse from −70 mV. The resting membrane potential was measured after establishment of the whole-cell configuration in neurons displaying stable membrane potential and no activity. The membrane potential values recorded in whole-cell configuration are corrected for a 10 mV junction potential, measured as described by Neher (1992). Neurons located in the SON and freshly dissociated neurons were selected on morphological [cell size and presence of a large dendrite corresponding to the α dendrite described by Hatton (1990)] and electrophysiological (high cell capacitance > 15 pF) criteria. Such large cells were shown to synthesize either OT or AVP at all stages of postnatal development (Hussy et al., 1997). OT, V1a, and V2 antagonists were applied through the general perfusion. OT and AVP were applied using a microperfusion system in close proximity to the recorded neurons. In the case of dissociated neurons, the general perfusion was switched off during the application of the peptides. The Ca2+-free solution was prepared as ACSF in which 2 mm CaCl2 was substituted by 2 mm MgCl2.

Measurement of peptide release from SON. Male Wistar rats (P2–P21) were killed by decapitation. After dissection (see Preparation of dissociated neurons), the SON were transferred into Locke buffer (maintained at 34°C) containing (in mm): NaCl 140, KCl 5, MgCl2 1.2, CaCl2 2.2, glucose 10, HEPES 10, pH 7.25; 298–300 mOsm/l. Three SON were incubated for AVP and OT release measurements. The tissues were preincubated with the Locke buffer at 34°C for ∼30–45 min during which they were rinsed every 5 min before collection of the samples. Five minute samples were collected; OT and AVP agonists were applied for 15 min. The released AVP and OT were assayed by radioimmunoassay (Cazalis et al., 1985) using specific antibodies (kindly supplied by Dr. R. J. Bicknell, Babraham Institute, Cambridge, UK). AVP and OT antisera were raised in sheep (the AVP antiserum was raised by Dr. Bicknell; the OT antisera were raised by Drs. E. L. Sheldric and A. P. Flint, Babraham Institute, Cambridge, UK). The final antibody dilution was 1:400,000 for AVP and 1:30,000 for OT. The cross-reactivity of the OT antiserum with AVP was 0.015%, whereas that of the AVP antiserum with OT was 0.001%. The sensitivities of the assays were 0.5 pg (AVP) and 1 pg (OT). The interassay and intra-assay coefficients of variation were 5–7% for AVP and 7–9% for OT.

Pharmacological compounds. OT antagonist (dOVT or Manning compound:d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]) was kindly provided by Dr. C. Barberis (Institut National de la Santé et de la Recherche Médicale U469, Montpellier, France). AVP antagonists [V1a antagonist: SR 49059:(2S) 1[(2R,3S)-(5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxybenzene-sulfonyl))-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl]-pyrro-lidine-2-carboxamide and V2 antagonist: SR 121463A: 1-[4-(N-tert-butylcarbamoyl)-2-metoxybenzene sulfonyl]-5-ethoxy-3-spiro-[4-(2-morpholino ethoxy) cyclohexane]-indol-2-one, furamate; equatorial isomer] were provided by Sanofi Synthelabo Recherche (Toulouse, France). AVP V1a agonist [F-180: Hmp-Phe-Ile-Hgn-Asn-Cys-Pro-Dab(Abu)-Gly-NH2; Ferring France, Gentilly, France] and OT agonist [(Thr4, Gly7)OT] were kindly provided by Dr. C. Barberis. AVP V2 agonist (dDAVP: 1-deamino-8-d-AVP) was kindly supplied by Dr J. L. Junien (Ferring France). OT and AVP were purchased from Calbiochem–Novabiochem (La Jolla, CA).125I-labeled AVP and OT were purchased from Amersham (Orsay, France). All salts were from Sigma (St. Quentin Fallavier, France). Results are expressed as mean ± SEM. Statistical analyzes were performed with ANOVA test.

RESULTS

The electrical activity of SON neurons in acute horizontal hypothalamic slices of 0- to 20-d-old rats was recorded in current-clamp using whole-cell and perforated patch-clamp techniques. The resting potential hyperpolarized during development, and the mean value between P0 and P20 was −45 ± 1 mV. During the first postnatal week, an unstable membrane potential led to erratic activity. From the second postnatal week onward, the membrane potential stabilized, and we observed an activity that progressively differentiated to become typical of mature SON neurons (Poulain and Wakerley, 1982), i.e., tonic for OT neurons and phasic for AVP neurons. The maturation of passive and active membrane properties of SON neurons during postnatal development will be described in detail elsewhere (V. Chevaleyre and M. G. Desarménien, unpublished observations).

Endogenous peptide release influences the electrical activity of maturing SON neurons

To test the involvement of somatodendritic release of endogenous peptides on cell electrical activity, OT and AVP receptor antagonists were added to the perfusion solution while we recorded from spontaneously active neurons. For AVP receptor blockade, V1a and V2 receptor antagonists were used because mature dissociated AVP neurons have been shown to respond to both V1a and V2 agonists (Gouzenes et al., 1999). Antagonists were applied on nine neurons that could be classified as putative OT or AVP neurons on the basis of their pattern of activity. The phasic pattern was not as sharp as in adult; however, some neurons could maintain a sustained activity for minutes, whereas other could not. Accordingly, neurons were considered as tonic if they displayed periods of activity for >3 min without interruption longer than 10 sec; neurons were stated as phasic if they displayed successive periods of activity and silence. Some neurons displayed irregular activities, without distinguishable pattern, and were not classified as tonic or phasic. Perfusion of an OT receptor antagonist (dOVT, 100 nm) led to a hyperpolarization (4–10 mV) and decreased the mean spike frequency (by 90%; n = 1) or suppressed (n = 4) the spontaneous activity of tonic neurons (Fig.1a). A combination of V1a and V2 receptor antagonists (SR 49059 and SR 121463A, respectively, each at 10 nm) induced a hyperpolarization (2–8 mV) and reduced the mean spike frequency (by 60 and 80%; n = 2) or abolished (n = 2) the spontaneous activity of phasic neurons (Fig. 1b). The effects of OT and AVP receptor antagonists were reversible in eight of nine neurons. These results show that OT and AVP are released under basal conditions within the SON and sustain the spontaneous electrical activity of SON neurons.

Fig. 1.
Fig. 1.

The spontaneous electrical activity of SON neurons is dependent on endogenous peptides release. a, Application of the OT antagonist (dOVT; 100 nm) on a tonic neuron (P16) reversibly hyperpolarized the membrane and suppressed the electrical activity. b, Application of V1a and V2 antagonists (SR 49059 and SR 121463A; 10 nm) on a phasic neuron (P15) also hyperpolarized the membrane and suppressed reversibly the electrical activity.

OT and AVP depolarize supraoptic neurons

The effects of OT and AVP (100 nm) were further characterized by local application of the peptides to the recorded neurons. Neurons were tested at the resting or slightly hyperpolarized voltages (to suppress spontaneous electrical activity masking small membrane potential changes). Among 74 neurons tested, 49 responded to only one peptide, 3 were sensitive to both, and 22 were unaffected by either peptide. OT (27 of 27 cells) and AVP (21 of 22 cells) induced depolarizations of similar amplitude (6 ± 1 mV) (Fig.2). The depolarization was accompanied by random or tonic firing of action potentials for OT-sensitive neurons (Fig. 2a) and random or phasic activity for AVP-sensitive neurons (Fig. 2b). In 1 of 22 neurons, AVP induced a hyperpolarization. Significantly, application of OT and AVP evoked a sustained depolarization lasting several minutes after the end of peptide application [application of 53 ± 6 sec; mean ratio (duration of the depolarization/duration of the application) of 3.66 ± 0.32, n = 44]. Similar long-lasting responses were observed using the perforated-patch technique (application of 47 ± 8 sec, mean ratio of 3.25 ± 0.65;n = 9), excluding the possibility that dialysis of a cytoplasmic component by the whole-cell procedure was responsible for a delayed recovery. In the three neurons sensitive to both OT and AVP, the depolarization induced by each peptide was of similar amplitude and duration. Interestingly, in one of these neurons, OT led to tonic activity, whereas the activity induced by AVP was phasic (data not shown). In the two other neurons, the duration of the response to each peptide was not sufficient enough to allow a characterization of the firing type induced. Besides, in some initially tonic neurons insensitive to OT, application of AVP induced phasic activity. This shows that each peptide depolarizes SON neurons and can trigger an electrical activity similar to the typical activity recorded in the mature respective neurons.

Fig. 2.
Fig. 2.

Application of OT and AVP led to a depolarization and an increased activity in supraoptic neurons. a, Example of a neuron (P9) responding to OT application (100 nm) by a sustained depolarization and a tonic activity. AVP had no effect in this neuron. b, Application of AVP (100 nm) on another neuron (P12) that was insensitive to OT led to a sustained depolarization and a phasic activity. These neurons have been slightly hyperpolarized before application of agonists to suppress the spontaneous activity.

To determine whether the site of action of the peptides is presynaptic or postsynaptic, OT and AVP were applied in the absence of extracellular Ca2+. The depolarizing effect of both peptides was persistent in the absence of Ca2+ (n = 3 for OT andn = 4 for AVP) (Fig.3a,b). However, the duration was significantly shorter than that observed in the presence of Ca2+ (application of 59 ± 4 sec; ratio of 1.75 ± 0.87; n = 15; p< 0.01). Because some synaptic activity can persist in Ca2+-free solution in the SON (Inenaga et al., 1998), this result suggests but does not demonstrate a postsynaptic action. To further address this question, OT and AVP were applied to acutely dissociated SON neurons. Both peptides induced depolarization (n = 4 for OT and n = 5 for AVP) (Fig.4a,b), confirming a postsynaptic mode of action. Again, briefer responses as compared with those observed in slices were induced by the peptides (application of 30 ± 2 sec, ratio of 2.35 ± 0.22, n = 14;p < 0.05). However, these responses were of longer duration than those obtained in Ca2+-free solution (p < 0.05).

Fig. 3.
Fig. 3.

OT- and AVP-induced depolarization persisted in Ca2+-free solution. Shown is an example of depolarization induced by OT (a) or AVP (b) in Ca2+-free/(4 mm) Mg2+ solution (P15 and P8, respectively). The absence of Ca2+ did not prevent the depolarization but accelerated the repolarization on washout of the peptide (compare with Fig. 2).

Fig. 4.
Fig. 4.

OT and AVP depolarize SON dissociated neurons. Application of OT (a) and AVP (b) led to a depolarization and an increased activity in dissociated supraoptic neurons (P8), showing that they act directly on these neurons. Note that the depolarizations were of shorter duration than those obtained in slices.

The effects of OT and AVP are maximum during a transitory period of development

We studied the incidence of the depolarization induced by OT and AVP from the day of birth to the last day before weaning (P0–P20). Neurons responded neither to OT nor to AVP before P4 (Fig.5). The first responding neurons were seen at P4. The incidence of the response increased to reach 100% by P7, and the incidence stayed maximal until P16. Then it dropped to 50% at P19–P20. No difference between the proportion of OT- and AVP-responding neurons was seen throughout the maturation.

Fig. 5.
Fig. 5.

Maturation of the autocontrol during postnatal development. a, Percentage of neurons responding to either OT or AVP (or both) versus postnatal age (in days).b, Amplitude of the depolarization induced by OT or AVP in responding neurons versus the postnatal age (in weeks). Means are significantly different between the first 2 weeks and the third postnatal week (p < 0.05). The number of neurons is represented in each bar.

As shown in Figure 5b, the amplitude of the depolarization induced by OT or AVP was similar during the first two postnatal weeks (6.5 ± 1 mV at P4–P6, n = 10, and 6 ± 0.5 mV at P7–P13, n = 24) and was significantly lower during the third postnatal week (4.5 ± 0.5 mV at P14–P20,n = 17; p < 0.05). This decrease in amplitude of the depolarization did not result from a decrease in membrane resistance (data not shown).

These results show that the depolarizing effect of the peptides is maximal during a transitory period of postnatal development. The peptides are released locally and lead to sustained depolarization of briefer duration in Ca2+-free solution or in dissociated neurons. This suggests a regenerative mechanism by a somatodendritic release of the peptides (which is also a Ca2+-dependent mechanism). We therefore determined whether the positive feedback loop could be closed by a facilitatory effect of the peptides on their own release.

OT and AVP selectively increase their own release from supraoptic nuclei

The release of OT and AVP from isolated SON was measured by radioimmunoassay. The specificity of the antibodies was checked by the absence of cross-reactivity between OT or AVP and their agonists (Fig.6a,b). At all ages studied, application of V1a agonist (F-180, 1 μm) and V2 agonist (dDAVP, 1 μm) increased the release of AVP (Fig. 6c). OT agonist [(Thr4, Gly7)OT, 1 μm] had no effect on AVP release (Fig. 6c). Conversely, the release of OT was increased by OT agonist but unaffected by both V1a and V2 agonist (Fig.6d).

Fig. 6.
Fig. 6.

OT and AVP increase selectively their own release from isolated SON. a, Radioimmunoassay displacement curve for vasopressin (●), F180 (Ago V1a, ▪), and dDAVP (Ago V2 , ▴) shows that the agonists do not cross-react with the AVP antiserum.Points are means of triplicate assays. b, Same as a with OT and (Thr4, Gly7)OT (Ago OT). c,d, Examples of experiments (P16 and P13, respectively) showing spontaneous and evoked AVP (c) and OT (d) release. Note the specific effect of each class of agonist on the release of its corresponding peptide.

Because the electrophysiological effects of the peptides displayed a transitory increase during development, we investigated whether the facilitatory effect on the release behaved similarly. As shown in Figure 7, the magnitude of the facilitation by the agonists increased between P2–P3 and P12–P13 (from ∼400% of basal release at P2–P3 to ∼700–800% at P12-P13). Then the evoked release decreased at P21 (200–300% of basal release) toward values in the range of those observed in adults (Moos et al., 1984; Wotjak et al., 1994). These data demonstrate that each peptide selectively increases its own release, and this effect is maximal during a transitory period of postnatal development.

Fig. 7.
Fig. 7.

Maturation of the evoked release of OT and AVP. The AVP release evoked by a V2 (black) or a V1a (gray) agonist and the OT release evoked by the OT agonist (white) are represented as the percentage of the basal release of AVP and OT, respectively. The number of experiments is represented above each bar. For V2 agonist, means are significantly different between P12–P13 and P2–P3 (p < 0.01) or P21(p < 0.001). For V1aagonist, means are significantly different between P12–P13 and P2–P3 (p < 0.05) or P21(p < 0.01). For OT agonist, means are significantly different between P12–P13 and P2–P3 (p < 0.05) or P21 (p < 0.01).

DISCUSSION

This study demonstrates that hypothalamic magnocellular neurons in the developing rat are positively autocontrolled by a local positive feedback using the peptide they synthesize. OT and AVP are released under basal conditions within the SON and sustain electrical activity of SON neurons. Application of each peptide depolarizes specifically one population of SON neurons as early as P4, showing that the neurons express functional receptors early in development. The proportion of neurons responding to the peptides reaches 100% at P7 and decreases, along with the amplitude of the depolarization, during the third postnatal week. This suggests that the positive feedback is progressively replaced by more complex actions of the peptides as described in adults (excitatory and inhibitory effects). Interestingly, the peptides have a facilitatory effect on their own release, and this action is also maximal during the second postnatal week. However, the facilitatory effects on the release are observed as soon as P2–P3, when the neurons do not yet display depolarization during OT or AVP stimulation. It is possible that the proportion of responding neurons is too small before P4. However, this apparent discrepancy may also reflect the fact that the depolarizing effect of the peptides and their action on the release rely on distinct mechanisms.

Characteristics of autocontrol

The depolarization induced by the peptides persisted in Ca2+-free solution and could be recorded on dissociated neurons, demonstrating a postsynaptic site of action. However, a presynaptic action as described in mature SON neurons (Kombian et al., 1997) is not excluded. The fact that brief depolarizations were observed in Ca2+-free solution suggests that a Ca2+-dependent process is involved in the maintenance of the response. Because the facilitatory effect of OT on its own release is a Ca2+-dependent mechanism in adult (Moos et al., 1984), it is probable that a somatodendritic release of endogenous peptide, induced by the initial depolarization or the applied peptide, prolongs the response. Consistent with this view, responses were also brief in dissociated neurons that have lost a large part of their dendritic tree, but they were longer than those observed in Ca2+-free solution, probably because the somatodendritic release has not been blocked.

In addition, our evidence indicates that OT and AVP act specifically on their secreting neurons. Indeed, each peptide increases selectively the electrical activity of one population of SON neurons and generally leads to the typical activity patterns of adult OT and AVP neurons (Poulain and Wakerley, 1982). Moreover, our release experiments show that each peptide increases only its own release, confirming that it acts selectively on neurons that secrete it. This specificity of action is in accordance with what is known in adult SON neurons. Electrophysiological recordings and calcium imaging in dissociated neurons, in slices or in vivo, have shown that most SON neurons respond solely to the peptide that they synthesize (Moos et al., 1984; Kawarabayashi et al., 1993; Wotjak et al., 1994; Dayanithi et al., 1996; Moos et al., 1998) and express only their corresponding receptors (Freund-Mercier et al., 1994; Hurbin et al., 1998). However, in this and in previous studies (Dayanithi et al., 1996), we found some neurons responding to both peptides, a fact that may be related to the existence of mixed electrophysiological phenotype neurons in vivo (Moos and Ingram, 1995) and of neurons synthesizing both peptides or both mRNAs (for review, see Gainer 1998).

In adult rats, the actions of the peptides are complex: excitatory and inhibitory effects have been described for both peptides. AVP has been reported to have no effect (Carette and Poulain, 1989), to increase (Inenaga and Yamashita, 1986), to decrease (Leng and Mason, 1982), or to have either effect on the firing of AVP neurons (Gouzenes et al., 1998). Various actions have also been reported for OT. It stimulates OT neurons in male rats and in ovariectomized, lactating, or parturient females (Kawarabayashi et al., 1993; Kuriyama et al., 1993); in cycling females, OT leads to an inhibition of OT neurons (Murai et al., 1998). Although the mechanisms of action of the peptides on the electrical activity are not fully understood, their principal role seems to maximize their systemic release via an appropriate patterning of the electrical activity (Moos et al., 1998). Our data show that in postnatal male rats, OT and AVP are almost exclusively excitatory. Both peptides depolarize SON neurons, and application of their receptor antagonists decreased electrical activity in all neurons tested. This positive feedback on the electrical activity and on the somatodendritic release indicates that an increased release in a single or few neurons can activate neighboring neurons expressing the same receptors and induce a propagating wave of excitation throughout the nucleus. Moreover, we show that this positive autocontrol is maximal in incidence and in amplitude during a limited period of postnatal development, suggesting that it could play a different role than favoring the systemic release as in adult rats.

Possible roles of autocontrol during development

Electrical activity regulates several developmental processes in the nervous system. One mechanism is by tuning electrical activity and [Ca2+]ifluctuations, which may influence various intracellular functions (Berridge, 1998). In the embryonic Xenopus spinal cord, the frequency of spontaneous calcium transients has been shown to regulate the number of neurons expressing GABA (Gu and Spitzer, 1995) and the rate of axon extension (Gomez and Spitzer, 1999). Hence, autocontrol of SON neurons is a way to induce or increase the electrical activity at a time when the neurons are poorly activated by afferents. This increased activity could also be important in increasing axonal release of the peptides. Indeed, even if OT and AVP are not involved in their main adult physiological roles, they are thought to act as developmental factors on peripheral organs (Carter et al., 1993). A neurotrophic action (by collaterals of paraventricular neurons, also containing OT and AVP) has also been suggested. A transient postnatal expression of OT and AVP binding sites has been described in several rat brain areas (Tribollet et al., 1991), and AVP promotes neurite outgrowth of embryonic Xenopus neurons (Brinton and Gruener, 1987). Therefore, this autocontrol, by increasing electrical activity and hence axonal release, could be important not only for OT and AVP neurons themselves but also for the maturation of other structures.

This autocontrol could also be involved in the selection of appropriate synaptic connections. In several brain areas, growing axons form initially imprecise connections during development, and increasing evidence suggests that coordination of neuronal activity is involved in the refinement of synaptic connections (Cramer and Sur, 1995). In the visual cortex or spinal cord, activities of related neurons are strongly coupled during the period when inappropriate connections are eliminated (Walton and Navarrete, 1991; Peinado et al., 1993; Kandler and Katz, 1998). In these examples, the coordination of the activity involves communication via gap junctions, transmitting either an electrotonic message in the case of motoneurons (Walton and Navarrete, 1991) or an intracellular diffusible messenger in cortical neurons (Kandler and Katz, 1998). Our results show that an extracellular messenger could also ensure the coordination of the activity of a specific population of SON neurons and hence participate in the specific innervation of OT and AVP neurons. This hypothesis is in accordance with the observation that monoaminergic afferents, even if they reach the hypothalamus during the late embryonic period, increase in number and only start to form connections during the second postnatal week (Ugrumov, 1992). This is also in accordance with a study showing that the connections between vagal afferents and OT neurons become functional between P2 and P10 (Nelson et al., 1998). Moreover, at the same time there is a transient increase in the density of the current supported by NMDA receptors (Hussy et al., 1997), which are known to be involved in shaping axonal arbors during development (Scheetz and Constantine-Paton, 1994). Finally, the neurons show important and transient increases in their dendritic shafts during the second postnatal week (V. Chevaleyre and M. G. Desarménien, unpublished results). Because autocontrol is maximal during this period, it could have important implications in the selection of specific OT or AVP afferents.

Conclusion

Whatever the exact role of autocontrol described here, it presents ideal characteristics for involvement in the maturation of SON neurons. OT and AVP increase electrical activity, and this action is amplified by a facilitatory effect on their own somatodendritic release. Each peptide acts selectively on its respective neuron in most cases, and maximal effects are concomitant with important developmental processes such as synapse formation or topographical segregation between OT and AVP neurons (Lazcano et al., 1990). Our data and those of previous investigators (Hussy et al., 1997; Ugrumov, 1992) show that the second postnatal week is a key period in the maturation of SON neurons, in which positive autocontrol could play important roles.

Footnotes

  • We thanks Drs. N. C. Spitzer and J. Valmier for careful reading of this manuscript, Drs. N. Hussy and A. Rabier for fruitful discussion, and A. Duvoid-Guillou for technical assistance.

    Correspondence should be addressed to Michel G. Desarménien, Centre National de la Recherche Scientifique Unité Propre de Recherche 9055, CCIPE, 141 Rue de la Cardonille, 34094 Montpellier Cedex, France. E-mail:mgdesa{at}bacchus.montp.inserm.fr.

REFERENCES

  1. ↵
    1. Berridge MJ
    (1998) Neuronal calcium signaling. Neuron 21:13–26.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Brinton RE,
    2. Gruener R
    Vasopressin promotes neurite growth in cultured embryonic neurons. Synapse 1 1987 329 334[Erratum (1988) 2:107].
    OpenUrlCrossRefPubMed
  3. ↵
    1. Carette B,
    2. Poulain P
    (1989) Vasopressin-sensitive neurons in the lateral paraventricular nucleus area in a guinea pig slice preparation. Brain Res Bull 22:969–974.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Carter DA,
    2. Fai CK,
    3. Murphy D
    (1993) Neurohypophyseal peptides as regulators of growth and development. A review. J Mol Neurosci 4:11–19.
    OpenUrlPubMed
  5. ↵
    1. Cazalis M,
    2. Dayanithi G,
    3. Nordmann JJ
    (1985) The role of patterned burst and interburst interval on the excitation-coupling mechanism in the isolated rat neural lobe. J Physiol (Lond) 369:45–60.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Cramer KS,
    2. Sur M
    (1995) Activity-dependent remodeling of connections in the mammalian visual system. Curr Opin Neurobiol 5:106–111.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Dayanithi G,
    2. Widmer H,
    3. Richard P
    (1996) Vasopressin-induced intracellular Ca2+ increase in isolated rat supraoptic cells. J Physiol (Lond) 490:713–727.
    OpenUrlPubMed
  8. ↵
    1. Di Scala-Guenot D,
    2. Strosser MT,
    3. Richard P
    (1987) Electrical stimulations of perifused magnocellular nuclei in vitro elicit Ca2+-dependent, tetrodotoxin-insensitive release of oxytocin and vasopressin. Neurosci Lett 76:209–214.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Freund-Mercier MJ,
    2. Richard P
    (1984) Electrophysiological evidence for facilitatory control of oxytocin neurones by oxytocin during suckling in the rat. J Physiol (Lond) 352:447–466.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Freund-Mercier MJ,
    2. Stoeckel ME,
    3. Klein MJ
    (1994) Oxytocin receptors on oxytocin neurones: histoautoradiographic detection in the lactating rat. J Physiol (Lond) 480:155–161.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Gainer H
    (1998) Cell-specific gene expression in oxytocin and vasopressin magnocellular neurons. Adv Exp Med Biol 449:15–27.
    OpenUrlPubMed
  12. ↵
    1. Gomez TM,
    2. Spitzer NC
    (1999) In vivo regulation of axon extension and pathfinding by growth-cone calcium transients. Nature 397:350–355.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Gouzenes L,
    2. Desarménien MG,
    3. Hussy N,
    4. Richard P,
    5. Moos FC
    (1998) Vasopressin regularizes the phasic firing pattern of rat hypothalamic magnocellular vasopressin neurons. J Neurosci 18:1879–1885.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Gouzenes L,
    2. Sabatier N,
    3. Richard P,
    4. Moos FC,
    5. Dayanithi G
    (1999) V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones. J Physiol (Lond) 517:771–779.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Gu X,
    2. Spitzer NC
    (1995) Distinct aspects of neuronal differentiation encoded by frequency of spontaneous Ca2+ transients. Nature 375:784–787.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Hatton GI
    (1990) Emerging concepts of structure-function dynamics in adult brain: the hypothalamo-neurohypophysial system. Prog Neurobiol 34:437–504.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Hurbin A,
    2. Boissin-Agasse L,
    3. Orcel H,
    4. Rabie A,
    5. Joux N,
    6. Desarménien MG,
    7. Richard P,
    8. Moos FC
    (1998) The V1a and V1b, but not V2, vasopressin receptor genes are expressed in the supraoptic nucleus of the rat hypothalamus, and the transcripts are essentially colocalized in the vasopressinergic magnocellular neurons. Endocrinology 139:4701–4707.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Hussy N,
    2. Boissin-Agasse L,
    3. Richard P,
    4. Desarménien MG
    (1997) NMDA receptor properties in rat supraoptic magnocellular neurons: characterization and postnatal development. Eur J Neurosci 9:1439–1449.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Inenaga K,
    2. Yamashita H
    (1986) Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin. J Physiol (Lond) 370:165–180.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Inenaga K,
    2. Honda E,
    3. Hirakawa T,
    4. Nakamura S,
    5. Yamashita H
    (1998) Glutamatergic synaptic inputs to mouse supraoptic neurons in calcium-free medium in vitro. J Neuroendocrinol 10:1–7.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Kandler K,
    2. Katz LC
    (1998) Coordination of neuronal activity in developing visual cortex by gap junction-mediated biochemical communication. J Neurosci 18:1419–1427.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Kawarabayashi T,
    2. Kuriyama K,
    3. Nakashima T,
    4. Kiyohara T,
    5. Sugimori H
    (1993) Oxytocin modulates oxytocin neurons in the paraventricular nuclei of female rats throughout pregnancy and parturition. Am J Obstet Gynecol 168:969–974.
    OpenUrlPubMed
  23. ↵
    1. Kombian SB,
    2. Mouginot D,
    3. Pittman QJ
    (1997) Dendritically released peptides act as retrograde modulators of afferent excitation in the supraoptic nucleus in vitro. Neuron 19:903–912.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Kuriyama K,
    2. Nakashima T,
    3. Kawarabayashi T,
    4. Kiyohara T
    (1993) Oxytocin inhibits nonphasically firing supraoptic and paraventricular neurons in the virgin female rat. Brain Res Bull 31:681–687.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Lazcano MA,
    2. Bentura ML,
    3. Toledano A
    (1990) Morphometric study on the development of magnocellular neurons of the supraoptic nucleus utilising immunohistochemical methods. J Anat 168:1–11.
    OpenUrlPubMed
  26. ↵
    1. Leng G,
    2. Mason WT
    (1982) Influence of vasopressin upon firing patterns of supraoptic neurons: a comparison of normal and Brattleboro rats. Ann NY Acad Sci 394:153–158.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Leng G,
    2. Brown CH,
    3. Russell JA
    (1999) Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol 57:625–655.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Moos F,
    2. Freund-Mercier MJ,
    3. Guerne Y,
    4. Guerne JM,
    5. Stoeckel ME,
    6. Richard P
    (1984) Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilitatory effect of oxytocin on its own release. J Endocrinol 102:63–72.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Moos F,
    2. Gouzenes L,
    3. Brown D,
    4. Dayanithi G,
    5. Sabatier N,
    6. Boissin L,
    7. Rabie A,
    8. Richard P
    (1998) New aspects of firing pattern autocontrol in oxytocin and vasopressin neurones. Adv Exp Med Biol 449:153–162.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Moos FC,
    2. Ingram CD
    (1995) Electrical recordings of magnocellular supraoptic and paraventricular neurons displaying both oxytocin- and vasopressin-related activity. Brain Res 669:309–314.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Murai Y,
    2. Nakashima T,
    3. Miyata S,
    4. Kiyohara T
    (1998) Different effect of oxytocin on membrane potential of supraoptic oxytocin neurons in virgin female and male rats in vitro. Neurosci Res 30:35–41.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Neher E
    (1992) Correction for liquid junction potentials in patch clamp experiments. Methods Enzymol 207:123–131.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Nelson EE,
    2. Alberts JR,
    3. Tian Y,
    4. Verbalis JG
    (1998) Oxytocin is elevated in plasma of 10-day-old rats following gastric distension. Brain Res Dev Brain Res 111:301–303.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Peinado A,
    2. Yuste R,
    3. Katz LC
    (1993) Extensive dye coupling between rat neocortical neurons during the period of circuit formation. Neuron 10:103–114.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Poulain DA,
    2. Wakerley JB
    (1982) Electrophysiology of hypothalamic magnocellular neurones secreting oxytocin and vasopressin. Neuroscience 7:773–808.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Pow DV,
    2. Morris JF
    (1989) Dendrites of hypothalamic magnocellular neurons release neurohypophysial peptides by exocytosis. Neuroscience 32:435–439.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Rajerison RM,
    2. Butlen D,
    3. Jard S
    (1976) Ontogenic development of antidiuretic hormone receptors in rat kidney: comparison of hormonal binding and adenylate cyclase activation. Mol Cell Endocrinol 4:271–285.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Scheetz AJ,
    2. Constantine-Paton M
    (1994) Modulation of NMDA receptor function: implications for vertebrate neural development. FASEB J 8:745–752.
    OpenUrlPubMed
  39. ↵
    1. Tribollet E,
    2. Goumaz M,
    3. Raggenbass M,
    4. Dreifuss JJ
    (1991) Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain. J Recept Res 11:333–346.
    OpenUrlPubMed
  40. ↵
    1. Ugrumov MV
    (1992) Development of the hypothalamic monoaminergic system in ontogenesis. Morpho-functional aspects. Zool Sci (Tokyo) 9:37–45.
    OpenUrl
  41. ↵
    1. Walton KD,
    2. Navarrete R
    (1991) Postnatal changes in motoneurone electrotonic coupling studied in the in vitro rat lumbar spinal cord. J Physiol (Lond) 433:283–305.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Wotjak CT,
    2. Ludwig M,
    3. Landgraf R
    (1994) Vasopressin facilitates its own release within the rat supraoptic nucleus in vivo. NeuroReport 5:1181–1184.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Email
Print
View Full Page PDF
Citation Tools
Respond to this article
Developmental Regulation of a Local Positive Autocontrol of Supraoptic Neurons
Vivien Chevaleyre, Govindan Dayanithi, Françoise C. Moos, Michel G. Desarménien
Journal of Neuroscience 1 August 2000, 20 (15) 5813-5819; DOI: 10.1523/JNEUROSCI.20-15-05813.2000
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Keywords

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.